Skip to Content
Merck
  • In vitro effects of a novel polysaccharide from the seeds of Plantago asiatica L. on intestinal function.

In vitro effects of a novel polysaccharide from the seeds of Plantago asiatica L. on intestinal function.

International journal of biological macromolecules (2012-12-19)
Jie-Lun Hu, Shao-Ping Nie, Chang Li, Ming-Yong Xie
ABSTRACT

Effects of a novel polysaccharide (PLP) from the seeds of Plantago asiatica L. on intestinal function were investigated in vitro. Results showed that PLP had notable influence on slowing down glucose diffusion and inhibiting α-amylase activity. These might help prolong blood glucose response and hence control the postprandial glucose concentration. PLP could also decrease pancreatic lipase and protease activities, which may help lower the levels of serum lipids and modify protein digestibility. In addition, PLP was able to bind bile acids and may reduce cholesterol level. These results suggested that PLP may have potential benefits for human intestinal function and might be used as a potential ingredient in functional food applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
α-Amylase from Bacillus sp., liquid
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~380 U/mg
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
Taka-Diastase from Aspergillus oryzae, powder, slightly beige, ~100 U/mg
Sigma-Aldrich
α-Amylase from porcine pancreas, PMSF Treated, Type I-A, saline suspension, ≥1000 units/mg protein (E1%/280)
Sigma-Aldrich
α-Amylase from Bacillus sp., Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Sigma-Aldrich
α-Amylase, heat-stable, solution, for use in Total Dietary Fiber Assay, TDF-100A
Sigma-Aldrich
α-Amylase from porcine pancreas, Type I-A, PMSF treated, saline suspension, 700-1400 units/mg protein (E1%/280)
Sigma-Aldrich
α-Amylase from porcine pancreas, Type VI-B, ≥5 units/mg solid
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
α-Amylase from human saliva, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-Amylase from human saliva, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
α-Amylase from Bacillus licheniformis, Type XII-A, saline solution, ≥500 units/mg protein (biuret)
Sigma-Aldrich
α-Amylase from Aspergillus oryzae, aqueous solution, ≥800 FAU/g
Sigma-Aldrich
α-Amylase from Bacillus amyloliquefaciens, liquid, ≥250 units/g
Sigma-Aldrich
α-Amylase from Bacillus licheniformis, lyophilized powder, 500-1,500 units/mg protein, 93-100% (SDS-PAGE)
Sigma-Aldrich
α-Amylase from Aspergillus oryzae, powder, ~30 U/mg
Sigma-Aldrich
α-Amylase from Aspergillus oryzae, ≥150 units/mg protein (biuret)
Sigma-Aldrich
α-Amylase from Aspergillus oryzae, powder, ~1.5 U/mg (~0.2 U acc. to Willstätter)